Role of Adjuvant Chemotherapy in Distal Cholangiocarcinoma

Seoul National University Hospital578 enrolled

Overview

Recent studies addressing the role of adjuvant chemotherapy in cholangiocarcinoma (CCA) have been published; however, there are challenges in generalizing the findings due to different prognostic characteristics depending on tumor location and resectability. Therefore, the aim of this study was to investigate the role of AC in distal cholangiocarcinoma, a common tumor subtype of CCA.

Study Type

OBSERVATIONAL

Enrollment

578

Conditions

Distal Cholangiocarcinoma Adjuvant Chemotherapy

Interventions

Adjuvant chemotherapyDRUG

Adjuvant chemotherapy with or without radiotherapy

Eligibility

Sex: ALLMin age: 19 YearsMax age: 90 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with distal cholangiocarcinoma who underwent surgery Exclusion Criteria: * Who underwent neoadjuvant treatment * Who underwent R2 resection * Non-adenocarcinoma patients in final pathology report * Insufficient data * Death within 90days of surgery

Outcomes

Primary Outcomes

Role of Adjuvant Chemotherapy in Distal Cholangiocarcinoma

Time frame: From January 2000 to December 2021

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.